Published in Can J Cardiol on January 01, 2006
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol (2007) 2.05
Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract (2011) 1.52
How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician (2011) 1.51
Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing. Can Respir J (2011) 1.36
Treating the right patient at the right time: access to heart failure care. Can J Cardiol (2006) 1.36
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2008) 1.25
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group. Curr Oncol (2008) 1.20
Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies. Cardiovasc Ultrasound (2007) 1.19
Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging (2007) 1.18
Reducing heart failure admission rates in England 2004-2011 are not related to changes in primary care quality: national observational study. Eur J Heart Fail (2013) 1.18
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol (2008) 1.15
Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. Can Fam Physician (2011) 1.09
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update. Can J Cardiol (2009) 1.03
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada. Can J Cardiol (2006) 1.02
End-of-life planning in heart failure: it should be the end of the beginning. Can J Cardiol (2010) 0.96
The epidemiology and management of elderly patients with myocardial infarction or heart failure. Heart Fail Rev (2010) 0.95
Anticoagulation in heart failure: current status and future direction. Heart Fail Rev (2013) 0.93
The underuse of digoxin in heart failure, and approaches to appropriate use. CMAJ (2007) 0.92
Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan. BMC Health Serv Res (2012) 0.91
Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol (2008) 0.90
Cardiorenal syndrome in heart failure: a cardiologist's perspective. Can J Cardiol (2008) 0.90
Link between decisions regarding resuscitation and preferences for quality over length of life with heart failure. Eur J Heart Fail (2011) 0.89
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol (2010) 0.89
Office management of patients with diastolic heart failure. CMAJ (2009) 0.88
Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? Can J Cardiol (2008) 0.88
Appropriateness of serum digoxin levels. Eur J Clin Pharmacol (2007) 0.87
Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways. BMC Palliat Care (2016) 0.87
Women with heart failure are at high psychosocial risk: a systematic review of how sex and gender influence heart failure self-care. Cardiol Res Pract (2011) 0.86
Dilemmas in end-stage heart failure. J Geriatr Cardiol (2015) 0.86
Development of the Champlain primary care cardiovascular disease prevention and management guideline: tailoring evidence to community practice. Can Fam Physician (2011) 0.86
Use, tolerability and compliance of spironolactone in the treatment of heart failure. BMC Clin Pharmacol (2011) 0.84
Current treatment options for early management in acute decompensated heart failure. Can J Cardiol (2008) 0.83
Towards National Evidence-Informed Practice Guidelines for Canadian EMS: Future Directions. Healthc Policy (2011) 0.83
Mind the gap: Opportunities for improving end-of-life care for patients with advanced heart failure. Can J Cardiol (2009) 0.83
Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics (2013) 0.82
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Role and benefits of exercise in the management of patients with heart failure. Heart Fail Rev (2010) 0.81
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure. Can J Cardiol (2009) 0.80
Understanding palliative care on the heart failure care team: an innovative research methodology. J Pain Symptom Manage (2012) 0.80
Quality of congestive heart failure care: assessing measurement of care using electronic medical records. Can Fam Physician (2010) 0.80
Molecular and physiological effects of nesiritide. Can J Cardiol (2008) 0.79
Prevention of heart failure in the elderly: when, where and how to begin? Heart Fail Rev (2012) 0.79
Necessary cautions when considering digoxin in heart failure. CMAJ (2007) 0.78
A qualitative study of the current state of heart failure community care in Canada: what can we learn for the future? BMC Health Serv Res (2015) 0.77
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. Circ Res (2016) 0.77
Physicians' perceptions of capacity building for managing chronic disease in seniors using integrated interprofessional care models. Can Fam Physician (2015) 0.76
Radionuclide Imaging of Viable Myocardium: Is it Underutilized? Curr Cardiovasc Imaging Rep (2011) 0.76
Can parathyroid hormone be used as a biomarker for heart failure? Heart Fail Rev (2013) 0.76
I have heart failure - what happens now, Doc? Can J Cardiol (2009) 0.75
Effects of a transitional palliative care model on patients with end-stage heart failure: study protocol for a randomized controlled trial. Trials (2016) 0.75
Evaluation of digoxin concentration after loading dose in patients with renal dysfunction. Can J Hosp Pharm (2013) 0.75
Peripartum cardiomyopathy. Ann Med Health Sci Res (2013) 0.75
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health. Nutrients (2016) 0.75
Cardiac effects of panhypopituitarism in a 71-year-old woman. CMAJ (2013) 0.75
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.75
The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma. Front Oncol (2015) 0.75
Targeting success in heart failure: evidence-based management. Can Fam Physician (2010) 0.75
Evaluating the scripts and thresholds of general practitioners for diagnosing heart failure in elderly people. BMC Fam Pract (2016) 0.75
Telerehabilitation for patients with heart failure. Cardiovasc Diagn Ther (2015) 0.75
Increased defibrillator therapies during influenza season in patients without influenza vaccines. J Arrhythm (2015) 0.75
Referral and use of heart failure clinics: what factors are related to use? Can J Cardiol (2012) 0.75
Predictors of implantable cardioverter-defibrillator use in patients with ischemic cardiomyopathy. Open Cardiovasc Med J (2010) 0.75
Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study. Open Cardiovasc Med J (2014) 0.75
Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure. Patient Prefer Adherence (2016) 0.75
Beta-blockers Associated with a Mortality Benefit in Patients with Systolic Dysfunction and Elevated Serum Bilirubin. Open Cardiovasc Med J (2014) 0.75
Does outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers. Can J Hosp Pharm (2012) 0.75
Acute decompensated heart failure: an introduction. Can J Cardiol (2008) 0.75
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure. Transl Med UniSa (2016) 0.75
Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban. Cardiol Res (2015) 0.75
Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study. SAGE Open Med (2016) 0.75
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 18.38
Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med (1990) 16.54
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA (1999) 15.73
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA (2003) 12.94
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med (2004) 12.52
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet (1999) 11.26
Understanding the treatment preferences of seriously ill patients. N Engl J Med (2002) 10.84
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet (1999) 10.07
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med (1987) 8.77
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med (1991) 6.65
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA (2005) 6.32
Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med (2005) 6.20
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med (1997) 5.93
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol (2004) 5.61
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med (1995) 5.22
Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci (2001) 5.09
New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation (2002) 4.96
Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med (2004) 4.72
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet (2001) 4.65
The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol (2004) 4.55
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation (2000) 3.98
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med (1998) 3.86
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
Frailty in elderly people: an evolving concept. CMAJ (1994) 3.84
Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry (1999) 3.82
The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc (2003) 3.79
Systematic review of multidisciplinary interventions in heart failure. Heart (2005) 3.68
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol (2004) 3.58
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ (2004) 3.39
Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J (1999) 3.38
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA (2003) 3.25
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA (2002) 3.24
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
Caregiving and risk of coronary heart disease in U.S. women: a prospective study. Am J Prev Med (2003) 3.10
A prospective study of delirium in hospitalized elderly. JAMA (1990) 3.02
Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation (2003) 3.01
Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA (1997) 2.92
The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J (2004) 2.85
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation (2002) 2.85
The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med (2003) 2.83
Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med (2004) 2.81
Myoblast transplantation for heart failure. Lancet (2001) 2.71
A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med (2004) 2.68
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61
Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol (2005) 2.38
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med (2004) 2.18
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2005) 2.13
Keeping your patient with heart failure safe: a review of potentially dangerous medications. Arch Intern Med (2004) 2.12
Acute precipitants of congestive heart failure exacerbations. Arch Intern Med (2001) 2.11
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Bioethics for clinicians: 6. Advance care planning. CMAJ (1996) 2.05
A multicenter disease management program for hospitalized patients with heart failure. J Card Fail (2004) 1.90
Diuretic therapy. N Engl J Med (1998) 1.86
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol (1996) 1.85
Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med (2000) 1.75
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol (2003) 1.67
The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med (2003) 1.65
Use of a ventilatory support system (BiPAP) for acute respiratory failure in the emergency department. Chest (1999) 1.63
Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials. Am J Cardiol (2005) 1.60
On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol (2003) 1.54
Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J (1994) 1.54
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
A meta-analysis of the association between adherence to drug therapy and mortality. BMJ (2006) 7.79
Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med (2014) 7.54
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med (2014) 4.86
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Self-denigration in pharmacy: Words to banish from the pharmacy lexicon / Autodénigrement en pharmacie : mots à bannir du vocabulaire des pharmaciens. Can Pharm J (Ott) (2014) 4.19
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res (2004) 3.93
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. J Hypertens (2014) 3.66
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet (2004) 3.40
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation (2004) 3.30
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol (2007) 3.23
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med (2008) 3.21
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott) (2013) 3.05
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol (2012) 3.03
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol (2012) 2.96
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA (2007) 2.89
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol (2008) 2.89
Poleward expansion of mangroves is a threshold response to decreased frequency of extreme cold events. Proc Natl Acad Sci U S A (2013) 2.86
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol (2007) 2.81
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol (2012) 2.77
Effect of fish oil on arrhythmias and mortality: systematic review. BMJ (2008) 2.76
Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation (2004) 2.74
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation (2004) 2.73
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm (2012) 2.65
Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ (2005) 2.57
Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]. Med Care (2009) 2.56
Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review. Int J Epidemiol (2009) 2.55
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55
Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med (2008) 2.55
Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med (2006) 2.53
Self-denigration in pharmacy: Actions that should be curtailed. Can Pharm J (Ott) (2014) 2.51
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail (2013) 2.50
A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain. Nat Cell Biol (2011) 2.43
Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail (2005) 2.41
Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg (2003) 2.39
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J (2005) 2.39
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36
Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med (2012) 2.35
Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg (2002) 2.31
Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30
Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg (2002) 2.30
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2005) 2.24
Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother (2005) 2.22
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care (2009) 2.19
Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll Cardiol (2002) 2.19
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis. Hepatology (2002) 2.17
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation (2003) 2.16
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation (2010) 2.13
Clopidogrel in acute coronary syndromes. BMJ (2009) 2.13
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail (2012) 2.13
Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges. J Am Coll Cardiol (2006) 2.11
Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J (2002) 2.09
Validity and reliability of the Edmonton Frail Scale. Age Ageing (2006) 2.08
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res (2012) 2.06
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol (2006) 2.06
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol (2007) 2.05
Stories from the trenches: Experiences of Alberta pharmacists in obtaining additional prescribing authority. Can Pharm J (Ott) (2012) 2.04
Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg (2004) 2.03
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology (2015) 2.02
Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant (2012) 2.01
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail (2011) 1.93
Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. Resuscitation (2010) 1.93
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA (2007) 1.91
Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol (2007) 1.91
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol (2011) 1.91
A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med (2013) 1.91
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91
Pharmacists' self-perception of their professional role: insights into community pharmacy culture. J Am Pharm Assoc (2003) (2011) 1.89